Skip to main content
Risk for MACEs higher in new users of IL12/23 and IL17 inhibitors vs TNF inhibitors in PsA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Risk for MACEs higher in new users of IL12/23 and IL17 inhibitors vs TNF inhibitors in PsA
User login
Username
Password
Reset your password
Type
Lead
score
Edit Tags